Iovance Biotherapeutics (IOVA) Change in Inventory (2023 - 2026)
Iovance Biotherapeutics (IOVA) posted quarterly Change in Inventory of $4.9 million for Q1 2026, down 64.36% year-over-year from $13.8 million in Q1 2025, and up 23.24% quarter-over-quarter from $4.0 million in Q4 2025.
Iovance Biotherapeutics (IOVA) Change in Inventory (2023 - 2026) Analysis & Trends
Iovance Biotherapeutics (IOVA) has reported Change in Inventory for 4 consecutive years, with $4.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Inventory fell 64.36% year-over-year to $4.9 million; the TTM figure through Mar 2026 stood at $5.3 million (down 89.69% YoY), while the FY2025 annual figure was $14.2 million, down 67.98% from the prior year.
- Change in Inventory grew to $4.9 million in Q1 2026 per IOVA's latest filing, from $4.0 million in the prior quarter.
- Across five years, Change in Inventory topped out at $18.9 million in Q4 2024 and bottomed at -$6.8 million in Q2 2025.
- Historically, Change in Inventory has averaged $6.1 million across 4 years, with a median of $5.8 million in 2024.
- Annual changes were most pronounced in 2024 — Change in Inventory soared 2885.59% — and 2025, when it sank 176.83%.
- Iovance Biotherapeutics' Change in Inventory stood at $923000.0 in 2023, then surged by 1950.6% to $18.9 million in 2024, then plunged by 78.86% to $4.0 million in 2025, then rose by 23.24% to $4.9 million in 2026.
- Business Quant data shows IOVA's Change in Inventory at $4.9 million in Q1 2026, $4.0 million in Q4 2025, and $3.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 27.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 28.20 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 47.15 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -2,188.52 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -280,000.00 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 12.97 Mn |
| 10 | Iovance Biotherapeutics | 3.16 Bn | 2.86 Bn | 55.72 Mn | 177,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 177,000.00 |
| Jun 30, 2026 | 177,000.00 |
| Mar 31, 2026 | 4.93 Mn |
| Mar 31, 2026 | 4.93 Mn |
| Dec 31, 2025 | 4.00 Mn |
| Dec 31, 2025 | 4.00 Mn |
| Sep 30, 2025 | 3.18 Mn |
| Sep 30, 2025 | 3.18 Mn |
| Jun 30, 2025 | -6.81 Mn |
| Jun 30, 2025 | -6.81 Mn |
| Mar 31, 2025 | 13.83 Mn |
| Mar 31, 2025 | 13.83 Mn |
| Dec 31, 2024 | 18.93 Mn |
| Dec 31, 2024 | 18.93 Mn |
| Sep 30, 2024 | 9.86 Mn |
| Sep 30, 2024 | 9.86 Mn |
| Jun 30, 2024 | 8.86 Mn |
| Jun 30, 2024 | 8.86 Mn |
| Mar 31, 2024 | 6.74 Mn |
| Mar 31, 2024 | 6.74 Mn |